Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001424884-16-000246
Filing Date
2016-07-14
Accepted
2016-07-14 16:31:01
Documents
58
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 583596
2 exhibit10-1.htm EX-10.1 23557
3 exhibit10-2.htm EX-10.2 17028
4 exhibit10-3.htm EX-10.3 112417
5 exhibit10-4.htm EX-10.4 32465
6 exhibit10-5.htm EX-10.5 141740
7 exhibit10-6.htm EX-10.6 22217
8 exhibit31-1.htm EX-31.1 18120
9 exhibit31-2.htm EX-31.2 17743
10 exhibit32-1.htm EX-32.1 7161
11 exhibit32-2.htm EX-32.2 7401
  Complete submission text file 0001424884-16-000246.txt   1984263

Data Files

Seq Description Document Type Size
12 ctbo-20160331.xml EX-101.INS 135374
13 ctbo-20160331.xsd EX-101.SCH 21193
14 ctbo-20160331_cal.xml EX-101.CAL 9595
15 ctbo-20160331_def.xml EX-101.DEF 37240
16 ctbo-20160331_lab.xml EX-101.LAB 103504
17 ctbo-20160331_pre.xml EX-101.PRE 94912
Mailing Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303
Business Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

EIN.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-54906 | Film No.: 161767673
SIC: 8741 Services-Management Services